bioRxivMicrobiology
Isoniazid resistance in Mycobacterium tuberculosis is a heterogeneous phenotype comprised of overlapping MIC distributions with different underlying resistance mechanisms
A. Ghodousi, E. Tagliani, E. Karunaratne, S. Niemann, J. Perera, C. U. Köser, D. M. Cirillo
Abstract
MIC testing using the BACTEC 960 MGIT system of 70 phylogenetically diverse, isoniazid-resistant clinical strains of Mycobacterium tuberculosis revealed a complex pattern of overlapping MIC distributions. Whole-genome sequencing could explain most of the level of resistance observed. The MIC distribution of strains with only inhA promoter mutations was split by the current concentration that is endorsed by the Clinical Laboratory Standards Institute to detect low-level resistance to isoniazid and is therefore likely not optimally set.
- organism: human
- assay: whole-genome sequencing
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Validation of novel Mycobacterium tuberculosis isoniazid resistance mutations not detectable by common molecular tests
J. L. Kandler, A. Mercante, … J. E. Posey·bioRxiv·May 15, 2018
- Predicting Isoniazid Resistance in Mycobacterium tuberculosis Complex in New York State using Whole Genome Sequencing
Kruthikaben Patel, Joseph Shea, … Kimberlee Arruda Musser·Journal of Clinical MicrobiologyPeer-reviewed·Mar 18, 2026
- Estimating MIC distributions and cutoffs through mixture models: an application to establish M. Tuberculosis resistance.
C. GRAZIAN·bioRxiv·May 20, 2019
- Genome-wide association studies of global Mycobacterium tuberculosis resistance to thirteen antimicrobials in 10,228 genomes
Sarah G. Earle, Daniel J. Wilson·bioRxiv·Sep 14, 2021
- Rifampicin tolerance and growth fitness among isoniazid-resistant clinical Mycobacterium tuberculosis isolates: an in-vitro longitudinal study
V. Srinivasan, N. L. H. Bao, … N. T. Thuong·bioRxiv·Nov 22, 2023
- Inducing vulnerability to InhA inhibition restores isoniazid susceptibility in drug resistant Mycobacterium tuberculosis
G. A. Harrison, K. Cho, … C. L. Stallings·bioRxiv·Feb 6, 2023